Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrative Modeling of PROTAC-Mediated Ternary Complexes
Gaoqi Weng, Dan Li, Yu Kang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 21, pp. 16271-16281
Closed Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

PROTACs: past, present and future
Ke Li, Craig M. Crews
Chemical Society Reviews (2022) Vol. 51, Iss. 12, pp. 5214-5236
Open Access | Times Cited: 425
Protein degraders enter the clinic — a new approach to cancer therapy
Deborah Chirnomas, Keith R. Hornberger, Craig M. Crews
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 265-278
Closed Access | Times Cited: 343
Chemistries of bifunctional PROTAC degraders
Chao-Guo Cao, Ming He, Liguo Wang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 16, pp. 7066-7114
Closed Access | Times Cited: 170
Chasing molecular glue degraders: screening approaches
Ana Domostegui, Luis Nieto‐Barrado, Carles Perez‐Lopez, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 13, pp. 5498-5517
Open Access | Times Cited: 104
PROTAC-DB 2.0: an updated database of PROTACs
Gaoqi Weng, Xuanyan Cai, Dongsheng Cao, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1367-D1372
Open Access | Times Cited: 100
Affinity and cooperativity modulate ternary complex formation to drive targeted protein degradation
Ryan P. Wurz, Huan Rui, Ken Dellamaggiore, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 53
Advancing Strategies for Proteolysis-Targeting Chimera Design
Minglei Li, Ying Zhi, Bo Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2308-2329
Closed Access | Times Cited: 46
Characteristic roadmap of linker governs the rational design of PROTACs
Yawen Dong, Tingting Ma, Ting Xu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4266-4295
Open Access | Times Cited: 24
PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery
Nicolas Guedeney, Marie Cornu, Florian Schwalen, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 1, pp. 103395-103395
Open Access | Times Cited: 66
In Silico Modeling and Scoring of PROTAC-Mediated Ternary Complex Poses
Junzhuo Liao, Xueqing Nie, Ilona Christy Unarta, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 8, pp. 6116-6132
Closed Access | Times Cited: 48
Importance of Three-Body Problems and Protein–Protein Interactions in Proteolysis-Targeting Chimera Modeling: Insights from Molecular Dynamics Simulations
Wenqing Li, Jiabin Zhang, Li Guo, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 3, pp. 523-532
Closed Access | Times Cited: 41
The importance of cellular degradation kinetics for understanding mechanisms in targeted protein degradation
Kristin M. Riching, Elizabeth A. Caine, Marjeta Urh, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 14, pp. 6210-6221
Open Access | Times Cited: 39
Biophysical and Computational Approaches to Study Ternary Complexes: A ‘Cooperative Relationship’ to Rationalize Targeted Protein Degradation
Jake A. Ward, Carles Perez‐Lopez, Cristina Mayor‐Ruiz
ChemBioChem (2023) Vol. 24, Iss. 10
Open Access | Times Cited: 35
Antiviral PROTACs: Opportunity borne with challenge
Jinsen Liang, Yihe Wu, Ke Lan, et al.
Cell Insight (2023) Vol. 2, Iss. 3, pp. 100092-100092
Open Access | Times Cited: 32
Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods
Barmak Mostofian, Holli‐Joi Martin, Asghar M. Razavi, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 17, pp. 5408-5432
Open Access | Times Cited: 29
PROTAC-DB 3.0: an updated database of PROTACs with extended pharmacokinetic parameters
Jingxuan Ge, Shimeng Li, Gaoqi Weng, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1510-D1515
Open Access | Times Cited: 11
PROTACable Is an Integrative Computational Pipeline of 3-D Modeling and Deep Learning To Automate the De Novo Design of PROTACs
Hazem Mslati, Francesco Gentile, Mohit Pandey, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 8, pp. 3034-3046
Open Access | Times Cited: 9
Quantum Mechanics-Based Ranking of Predicted Proteolysis Targeting Chimeras-Mediated Ternary Complexes
Stefania Monteleone, Iñaki Morao, Dmitri G. Fedorov, et al.
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 3, pp. 420-427
Closed Access | Times Cited: 1
MEGA PROTAC, MEGA DOCK-based PROTAC mediated ternary complex formation pipeline with sequential filtering and rank aggregation
Sadettin Yavuz Ugurlu, David W. McDonald, Ramazan Enisoglu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
In silico modeling of targeted protein degradation
Wenxing Lv, Xiaojuan Jia, Bowen Tang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117432-117432
Open Access | Times Cited: 1
Machine Learning Modeling of Protein-Intrinsic Features Predicts Tractability of Targeted Protein Degradation
Wubing Zhang, Shourya S. Roy Burman, Jiaye Chen, et al.
Genomics Proteomics & Bioinformatics (2022) Vol. 20, Iss. 5, pp. 882-898
Open Access | Times Cited: 31
Towards design of drugs and delivery systems with the Martini coarse-grained model
Lisbeth R. Kjølbye, Gilberto P. Pereira, Alessio Bartocci, et al.
QRB Discovery (2022) Vol. 3
Open Access | Times Cited: 29
3D based generative PROTAC linker design with reinforcement learning
Baiqing Li, Ting Ran, Hongming Chen
Briefings in Bioinformatics (2023) Vol. 24, Iss. 5
Closed Access | Times Cited: 21
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease
Melissa Guardigni, Letizia Pruccoli, Alan Santini, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 1963-1970
Open Access | Times Cited: 19
Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer
Lin Ma, Yingying Li, Ruixiang Luo, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7438-7453
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top